Novo Nordisk Earnings: Wegovy Pill Beats Forecasts as Novo Raises Outlook
Novo Nordisk earnings: Q3 sales of 79.2 billion kroner beat forecasts as the Wegovy pill took in 5.4 billion, and Novo raised its 2026 outlook. Data inside.
GLP-1 drugs